LEXINGTON, Mass. — August 26, 2025 — Leads & Copy — Voyager Therapeutics, Inc. (Nasdaq: VYGR) will participate in several upcoming investor conferences.
The conferences include Citi’s 2025 Biopharma Back to School Conference on September 2, the 2025 Wells Fargo Healthcare Conference on September 3, the Cantor Global Healthcare Conference 2025 on September 4, the Morgan Stanley 23rd Annual Global Healthcare Conference on September 8, the Baird 2025 Global Healthcare Conference and H.C. Wainwright 27th Annual Global Investment Conference, both on September 9.
Webcasts of the Citi and Baird fireside chats will be available on Voyager’s website, with replays archived for at least 30 days.
Voyager Therapeutics is focused on using human genetics to treat neurological diseases, with programs for Alzheimer’s, Friedreich’s ataxia, Parkinson’s, ALS, and other CNS diseases. Their TRACER™ AAV capsid discovery platform aims to enable high brain penetration with genetic medicines.
Contacts:
Trista Morrison, NACD.DC, tmorrison@vygr.com
Investors: Sarah McCabe, smccabe@jpa.com
Media: Adam Silverstein, adam@scientpr.com
Source: Voyager Therapeutics, Inc.
